Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

Clinical trial NCT00734435 · TERMINATED

Trial details

NCT number: NCT00734435
Sponsor: Orexigen Therapeutics, Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Schizophreniform Disorder

Start date: 2008-09-01
Primary completion: 2008-12-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.